Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Sep;8(9):2383-2386.
doi: 10.21037/jtd.2016.08.92.

Dual bronchodilation and exacerbations of COPD

Affiliations
Editorial

Dual bronchodilation and exacerbations of COPD

Mario Cazzola et al. J Thorac Dis. 2016 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Comment on

  • Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
    Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Clinical Trial.

References

    1. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease. Available online: http://goldcopd.org/ - PubMed
    1. Wedzicha JA, Decramer M, Ficker JH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med 2013;1:199-209. 10.1016/S2213-2600(13)70052-3 - DOI - PubMed
    1. Calzetta L, Rogliani P, Matera MG, et al. A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD. Chest 2016;149:1181-96. 10.1016/j.chest.2016.02.646 - DOI - PubMed
    1. Calzetta L, Matera MG, Cazzola M. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy. Eur J Pharmacol 2015;761:168-73. 10.1016/j.ejphar.2015.05.020 - DOI - PubMed
    1. Cazzola M, Calzetta L, Segreti A, et al. Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. COPD 2015;12:175-81. 10.3109/15412555.2014.922172 - DOI - PubMed